Biologics CDMO Market Expected to Witness Sustainable Growth over 2024: BIS Research

Biologics Contract Development and Manufacturing Organizations (CDMOs) are key players in the pharmaceutical industry, providing crucial support for developing and manufacturing complex biologic drugs derived from living cells or organisms. These drugs include monoclonal antibodies, vaccines, gene, and cell-based therapies. The market for biologics CDMOs is witnessing significant trends driven by technological advancements and increased research and development activities. Key trends include the growing demand for biologics globally, the rise of biosimilar development, the emergence of cell and gene therapies, and the increasing adoption of single-use technologies in bioprocessing to enhance efficiency and flexibility. 

Access Market Insights: Biologics CDMO Market 

Biologics CDMO Market Analysis: Drivers, Challenges, and Opportunities 

The demand for biologics is driven by several pharmaceutical industry factors. Notably, there's a significant increase in biologics approvals and development, spurred by advancements in biotechnology and expanding therapeutic indications.  

The prevalence of chronic infectious diseases is on the rise, further fueling the demand for biologic drugs. Moreover, investing in contract manufacturing facilities offers advantages such as cost-effectiveness and scalability, encouraging pharmaceutical companies to outsource manufacturing processes.  

However, stringent regulatory requirements pose challenges and a shortage of skilled professionals in bioprocessing and biomanufacturing. Despite these constraints, opportunities, particularly in emerging markets like China, offer new outsourcing opportunities and the potential for additional alliances between Contract Development and Manufacturing Organizations (CDMOs) and big pharmaceutical firms. 

BIS Research released the Biologics Contract Development and Manufacturing Organization (CDMO) market report, which covers 2023 to 2032, with a base year of 2022. In 2022, the market size was $19.00 billion, and it is projected to reach $80.05 billion by 2032, with a compound annual growth rate (CAGR) of 15.43% during the forecast period. 

Evaluate Free Sample Report: Download Sample Report 

Key Players in the Biologics CDMO Market 

•   AbbVie Inc. 

•   AGC Biologics 

•   Binex Co. Limited 

•   Boehringer Ingelheim International GmbH 

•   Catalent, Inc 

•   Lonza 

•   Novartis AG 

•   Parexel International Corporation 

•   Samsung Biologics 

•   Toyobo Co., Ltd. 

Biologics CDMO Market Segments 

Segmentation 1: by Cell Type 

•   Mammalian 

•   Microbial and Others 

Segmentation 2: by Indication 

•   Oncology 

•   Auto-Immune Diseases 

•   Infectious Diseases 

•   Neurology 

•   Others 

Segmentation 3: by Molecule Type 

•   Monoclonal Antibodies 

•   Recombinant Proteins 

•   Vaccines 

•   Hormones 

•   Others 

Segmentation 4: by Region 

•   North America 

•   Europe 

•   Asia-Pacific 

•   Latin America 

•   Middle East and Africa 

Overview: The global Biologics Contract Development and Manufacturing Organization (CDMO) market is segmented based on cell type, indication, molecule type, and region. In FY2022, the mammalian cell type dominated the market due to its accuracy in replicating complex proteins, especially for monoclonal antibodies. Oncology led the indication segment, reflecting the focus on cancer research and therapies. Monoclonal antibodies were the primary molecule type, favored for their targeted treatment capabilities. China held a significant share in the Asia-Pacific region, poised for the highest growth rate, driven by rising demand and technological advancements, especially in addressing chronic diseases. 

Table of Contents   

1.1   Trends: Current and Future Impact Assessment  

1.2   Supply Chain Overview  

1.3   Research and Development Review  

1.4   Regulatory Landscape  

1.5   Stakeholder Analysis  

1.7   Market Dynamics Overview  

2.1   Application Segmentation  

2.2   Application Summary 

3.1   Product Segmentation 

3.2   Product Summary 

4.1   Regional Summary 

To Evaluate Report Coverage: Access Full TOC 

Other Related Reports from BIS Healthcare 

Synthetic Hormones Market 

Clinical Biomarkers Market 

Highly Potent API Market 

Korea Centrifugation Market 

Digital Therapeutics Market 

Organ Transplant Diagnostics Market 

Analyst Take on the Biologics CDMO Market 

BIS Principal Analyst: New entrants in the biologics CDMO market can gain a competitive edge by investing in cutting-edge technologies and advanced facilities for bioprocessing and analytics to ensure efficient production. Emphasizing flexibility and scalability in manufacturing processes will attract clients with diverse needs. Developing expertise in emerging areas like cell and gene therapies, biosimilars, and personalized medicine can establish the company as an industry leader. This report is valuable for CDMOs/CROs/CMOs producing biologics, biologics manufacturers, pharmaceutical companies, and new entrants seeking insights into opportunities in the biologics CDMO market. 

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing   

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch